Corning Incorporated today introduced Corning Velocity® Vials, which the company says will help “industry-leading drugmakers respond to the COVID-19 pandemic at speed.”
The specially engineered Type I borosilicate vials are externally coated with the company’s “proprietary technology,” which Corning says leads to increased efficiency and speed of the Velocity Vials’ manufacturing.